Results 151 to 160 of about 2,126,918 (327)
Principal component analysis of Motokawa's data on wavelength dependence of retinal processes.
Kitsuya Iwama
openalex +2 more sources
Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova+18 more
wiley +1 more source
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma+9 more
wiley +1 more source
Robust sparse smooth principal component analysis for face reconstruction and recognition. [PDF]
Wang J+5 more
europepmc +1 more source
ILLUSTRATIVE EXAMPLES OF PRINCIPAL COMPONENTS ANALYSIS
Walter T. Fédérer+2 more
openalex +2 more sources
Rejoinder: Analysis of Additive Dependencies and Concurvities Using Smallest Additive Principal Components [PDF]
Deborah Donnell+2 more
openalex +1 more source
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu+12 more
wiley +1 more source
Evaluating the Output Performance of the Semiconductor Bridge Through Principal Component Analysis. [PDF]
Zhang L+8 more
europepmc +1 more source
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci+6 more
wiley +1 more source